• Explore /
  • Poster
  • / Randomized phase III study of gemcitabine plus S-1 combination therapy versus gemcitabine plus cisplatin combination therapy in advanced biliary tract cancer: A Japan Clinical Oncology Group study (JCOG1113).

Randomized phase III study of gemcitabine plus S-1 combination therapy versus gemcitabine plus cisplatin combination therapy in advanced biliary tract cancer: A Japan Clinical Oncology Group study (JCOG1113).

Abstract Poster

Authors

Chigusa Morizane

Chigusa Morizane

Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan

Chigusa Morizane , Takuji Okusaka , Junki Mizusawa , Hiroshi Katayama , Makoto Ueno , Masafumi Ikeda , Hiroshi Ishii , Takeshi Azuma , Haruo Iguchi , Shoji Nakamori , Nobumasa Mizuno , Naohiro Sata , Kazuya Sugimori , Kensei Yamaguchi , Tetsuya Mine , Keiji Sano , Hiroyuki Maguchi , Kyoko Shimizu , Junji Furuse

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer

Clinical Trial Registration Number

UMIN000010667

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr TPS4149)

DOI

10.1200/jco.2014.32.15_suppl.tps4149

Abstract #

TPS4149

Poster Bd #

233B

Abstract Disclosures

Similar Posters

First Author: Makoto Ueno

First Author: Chigusa Morizane

First Author: Tatsuya Ioka

First Author: Aiwu He